Ismael Alvarez-Alvarez

15PUBLICATIONS
55CO-AUTHORS
Molecular targetsBiomolecular modelling and designAutoimmunityNatural products and bioactive compoundsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Mar 26, 2025
Epigenetic modifications in drug-induced liver injury: A systematic review.

Romina Lorena de Los Santos-Fernández, Antonio Segovia-Zafra, Guillermo Paz-López

|Feb 21, 2025
Artificial Intelligence: An Emerging Tool for Studying Drug-Induced Liver Injury.

Hao Niu, Ismael Alvarez-Alvarez, Minjun Chen

|Jun 03, 2023
Clinical presentation, causative drugs and outcome of patients with autoimmune features in two prospective DILI registries.

Miren García-Cortés, Aida Ortega-Alonso, Gonzalo Matilla-Cabello

|Jan 21, 2023
Organophosphate pesticides: Another silent liver hazard?

Ismael Alvarez-Alvarez, Raúl J Andrade

|Dec 22, 2022
Potential benefit and lack of serious risk from corticosteroids in drug-induced liver injury: An international, multicentre, propensity score-matched analysis.

Hao Niu, Jiayi Ma, Inmaculada Medina-Caliz

|Nov 23, 2022
Nitrofurantoin-induced liver injury: long-term follow-up in two prospective DILI registries.

Fernando Bessone, Antonella Ferrari, Nelia Hernandez

Pageof 3

Frequent Collaborators

12 joint publications

Raúl J Andrade

11 joint publications

Mª Isabel Lucena

8 joint publications

Inmaculada Medina-Cáliz

8 joint publications

Hao Niu